REVERSAL OF DRUG-RESISTANCE IN MULTIPLE-MYELOMA WITH VERAPAMIL

被引：96

作者：

DURIE, BGM ^{[1
]}

DALTON, WS ^{[1
]}

机构：

[1] ARIZONA HLTH SCI CTR,ARIZONA CANC CTR,TUCSON,AZ 85724

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1988年 / 68卷 / 02期

关键词：

D O I：

10.1111/j.1365-2141.1988.tb06190.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：203 / 206

页数：4

共 11 条

[1]

AKLYAMA S, 1986, J NATIONAL CANCER I, V76, P839

[2] EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J].

BARLOGIE, B ;

SMITH, L ;

ALEXANIAN, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1353-1356

[3] PLEIOTROPIC PHENOTYPE OF COLCHICINE-RESISTANT CHO CELLS - CROSS-RESISTANCE AND COLLATERAL SENSITIVITY [J].

BECHHANSEN, NT ;

TILL, JE ;

LING, V .

JOURNAL OF CELLULAR PHYSIOLOGY, 1976, 88 (01) :23-31

[4]

DALTON WS, 1986, CANCER RES, V46, P5125

[5]

KYLE RA, 1984, NEW ENGLAND J MED, V310, P1381

[6]

MA DDF, 1987, LANCET 0117

[7]

OZOLS RF, 1984, P AM ASSOC CANC RES, V25, P300

[8] GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF MULTIDRUG RESISTANCE [J].

RIORDAN, JR ;

LING, V .

PHARMACOLOGY & THERAPEUTICS, 1985, 28 (01) :51-75

[9]

ROSS DD, 1986, BLOOD, V68, P83

[10]

TARTAGLIONE TA, 1983, RES COMMUN CHEM PATH, V40, P15

← 1 2 →